Pieris Pharmaceuticals In... (PIRS)
NASDAQ: PIRS
· Real-Time Price · USD
13.60
-2.51 (-15.58%)
At close: Dec 13, 2024, 10:00 PM
Pieris Pharmaceuticals Revenue
Pieris Pharmaceuticals reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending March 31, 2025, Pieris Pharmaceuticals generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
0
Employees
46
Market Cap
17.96M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 0 | -100.00% |
| Dec 31, 2023 | 42.81M | +65.28% |
| Dec 31, 2022 | 25.9M | -17.56% |
| Dec 31, 2021 | 31.42M | +7.14% |
| Dec 31, 2020 | 29.32M | -36.64% |
| Dec 31, 2019 | 46.28M | +59.03% |
| Dec 31, 2018 | 29.1M | +15.14% |
| Dec 31, 2017 | 25.27M | +333.48% |
| Dec 31, 2016 | 5.83M | +98.87% |
| Dec 31, 2015 | 2.93M | -45.35% |
| Dec 31, 2014 | 5.37M | -45.70% |
| Dec 31, 2013 | 9.88M | -13.21% |
| Dec 31, 2012 | 11.38M | n/a |